Evaluation of Common Genetic Disorders in Myeloproliferative Neoplasms [PDF]
Introduction: The myeloproliferative neoplasms (MPNs) are a heterogeneous group of diseases characterized by excessive production of blood cells by hematopoietic precursors. Typically, they include polycythemia vera (PV), essential thrombocythemia (ET),
Mehrdad Payandeh +7 more
doaj +1 more source
Allosteric inhibition enhances the efficacy of ABL kinase inhibitors to target unmutated BCR-ABL and BCR-ABL-T315I [PDF]
Background: Chronic myelogenous leukemia (CML) and Philadelphia chromosome-positive (Ph+) acute lymphatic leukemia (Ph + ALL) are caused by the t(9;22), which fuses BCR to ABL resulting in deregulated ABL-tyrosine kinase activity.
Ruimi, Nili +18 more
core +1 more source
Bilateral Serous Retinal Detachment in Lymphoid Blast Crisis of Chronic Myeloid Leukemia
We herein report a patient with Philadelphia chromosome-positive lymphoid blast crisis of chronic myeloid leukemia (CML), who presented with bilateral serous retinal detachment (SRD).
Kyohei Umemura +4 more
doaj +1 more source
Reduced‐intensity therapy for relapsed Philadelphia chromosome‐positive leukemia [PDF]
Citation: Shun Nagasawa, Ai Yamada, Midori Nakagawa, Mariko Kinoshita, Yuhki Koga, Shouichi Ohga, Hiroshi Moritake, Reduced‐intensity therapy for relapsed Philadelphia chromosome‐positive leukemia, Pediatric Blood & Cancer, 71(2), 2023-12-05, https://doi.
Kinoshita, Mariko +17 more
core
We present a unique case of pediatric B lymphoblastic leukemia with Philadelphia chromosome, CD56 expression, and predominantly L2 morphology. A review of the current literature demonstrates that this distinct combination of features is rare and may ...
Jadee Neff, MD, PhD, Dong Chen, MD, PhD
doaj +1 more source
Philadelphia chromosome-positive pre-B lymphoblastic leukemia presenting as acute hepatic failure in a pediatric ...
ZoAnn E. Dreyer (11856584) +5 more
core +1 more source
Applying the discovery of the Philadelphia chromosome [PDF]
The identification of the Philadelphia chromosome in cells from individuals with chronic myelogenous leukemia (CML) led to the recognition that the BCR-ABL tyrosine kinase causes CML. This in turn led to the development of imatinib mesylate, a clinically successful inhibitor of the BCR-ABL kinase.
Daniel W, Sherbenou, Brian J, Druker
openaire +2 more sources
Avaliação de parâmetros laboratoriais e clínicos de pacientes portadores de leucemia mielóide crônica submetidos ao tratamento com mesilato de imatinibe e sua relação com alterações observadas no estroma da medula óssea Correlation between laboratory and clinical parameters of chronic myeloid leukemia patients treated with imatinib mesylate and its relationship with stromal changes observed in bone marrow biopsy [PDF]
Dissertação (mestrado) - Universidade Federal de Santa Catarina, Centro de Ciências da Saúde. Programa de Pós-graduação em FarmáciaA leucemia mieloide cronica (LMC) e uma doenca mieloproliferativa clonal, responsavel por 14% de todos os casos de ...
Caroline R. de Jesus +1 more
core +1 more source
"Transformation of chronic myelogenous leukemia to Multiple Myeloma: A case report " [PDF]
Chronic myelogenous leukemia (CML) is a stem cell disorder sometimes associated with lymphoproliferative disorders. CML may precede a lymphoproliferative disorder.
"Ghavamzadeh A +5 more
doaj +1 more source
Background Chronic myeloid leukemia is a hematologic malignancy associated with the fusion of two genes: BCR and ABL1. This fusion results from a translocation between chromosomes 9 and 22, which is called the Philadelphia chromosome.
Yuka Torii +12 more
doaj +1 more source

